Skip to content

PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy

Unknown statusNCT03392948
View the official record on ClinicalTrials.gov

Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.

This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.

Brief summary (from the registry)

Approximately 5 to 8% of patients undergoing percutaneous coronary interventions requires chronic anticoagulant therapy due to atrial fibrillation or other clinical entities. There are many possible different combinations of the antithrombotic therapy after stent implantation in these patients. Aim of this observational study is to evaluate the real world antithrombotic treatment in patients requiring anticoagulant therapy undergoing stent implantation and to compare the clinical outcome of patients treated with new oral anticoagulant drugs compared to warfarin. The study is prospective, performed in different Italian hospitals and aimed to enroll 1080 patients with a 1 year follow up

Study details

Official title
PERcutaneouS Coronary intErventions in Patients Treated With Oral Anticoagulant Therapy
Conditions
Sponsor
Italian Society of Invasive Cardiology
Start date
2018-02-09
Primary completion
2022-02-28
Sex
All
Age range
from 18 Years
Results posted
No results posted in this snapshot
Countries
Italy
Total sites listed
10

Eligibility criteria

Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * All patients undergoing percutaneous coronary interventions with stent and an indication for chronic anticoagulant therapy. Exclusion Criteria: * Patients of age \< 18 years old * Lack of written informed consent to participate in the study

Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT03392948